The development of Jack Jumper ant venom immunotherapy: our 25 years' experience.

Authors :: Wanandy, Troy
Le, Thanh‐Thao A.
Lau, Wun Y.
Wiese, Michael D.
Heddle, Robert J.
Brown, Simon G. A.
Source :: Internal Medicine Journal; Sep2023, Vol. 53 Issue 9, p1716-1721, 6p
Publication Year :: 2023
Abstract: Jack Jumper ant venom allergy is a uniquely Australian medical issue. The stinging ant is a leading cause of insect venom allergy in south‐eastern Australia. An effective venom immunotherapy‐based treatment was successfully developed by the Tasmanian Jack Jumper Allergy Research group. This paper provides a synopsis of our 25 years' research journey in developing this evidence‐based treatment modality. [ABSTRACT FROM AUTHOR]

Subjects :: VENOM
BITES & stings
HOSPITAL emergency services
TREATMENT effectiveness
VENOM hypersensitivity
INSECTS
DRUG development
IMMUNOTHERAPY
DISEASE risk factors

Full Text Access

Tools